Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.
Karin Kottig
Advertisement
Karin Kottig, PhD, is head of Contract Service Analytics, Vetter Development Service.
Articles by Karin Kottig
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5